HiMed-Biodesign MedTech Accelerator Program – Baxter Dialysis & Critical Care Track Launches

HiMed-Biodesign Medical Innovation Camp, in partnership with Baxter Healthcare, proudly launches an acceleration program targeting dialysis, critical care, and digital health. We are recruiting diverse talents to join us. Guided by Stanford Biodesign’s philosophy of medical technology innovation, the program fosters deep interdisciplinary exchange and integrates clinical expertise with engineering through seed incubation, empowering healthcare tech entrepreneurs and injecting new vitality into industry development.

The Medical Innovation Accelerator Program will officially launch in October 2021. We are currently recruiting approximately 40 early-stage medical entrepreneurs and innovators to participate in a two-day program featuring theoretical instruction and practical pitch sessions. Subsequently, high-potential founders will be selected to join the accelerator camp for in-depth learning and incubation.

Course Objectives: To understand the Biodesign medical technology innovation process system, experience the entrepreneurial atmosphere, and spark innovative ideas through theoretical lectures, startup simulations, and live pitch sessions.

1. Discovery and Identification: Real Clinical Needs

2. Research and Assessment: Disease State Fundamentals and Existing Solutions

3. Analysis and Requirement Screening: Stakeholder and Market Analysis

1. Product Concept Ideation and Brainstorming

2. Concept Screening and Prototype Design

3. Prototype Testing and Final Concept Selection

1. Strategic Development: Intellectual Property/R&D/Health Insurance/Regulation, etc.

2. Business Plan: Marketing Strategy and Financial Model

3. Business Plan and Fundraising Training

Registration Deadline: October 7

Recruitment & Screening of Participants (40 spots, merit-based selection)

The final batch confirmed on October 8.

Confirmation in batches, subject to SMS notification.

Mandatory 2-Day Training, October 15–16

Venue: 5th Floor, Building B, No. 58 Xiangke Road, Zhangjiang Science City, Shanghai

Phase I Accelerator Camp November 4

3-4 Month Accelerator Camp

*Note: In the event of special circumstances such as an epidemic, the Medical Innovation Camp will be postponed or otherwise arranged at our discretion; please refer to the SMS notification for specific details.

Scan or recognize the QR code below to register.

Contact for Inquiries:

Xiao Mai: 19916567386 (Mobile/WeChat)

Nancy: 15618033086 (Mobile/WeChat)

Submit BP: BP@joyincenter.com

HiMed-Biodesign Medical Innovation Camp, refined over eight years of curriculum development, has held six domestic and four international sessions, fostering a collaborative alliance of more than 200 alumni.

The School of Medical Instrument and Food Engineering at the University of Shanghai for Science and Technology, established in 2003, is one of China’s premier institutions for cultivating talent in the medical device sector. It currently offers doctoral programs and postdoctoral research stations in the primary discipline of Biomedical Engineering, and has been recognized as a National First-Batch First-Class Undergraduate Major and a Shanghai High-Level First-Class Discipline. The school hosts several national and municipal research platforms, including the Ministry of Education’s Research Center for Modern Minimally Invasive Medical Devices and Technologies Engineering, a National Continuing Education Base for Professional and Technical Personnel, and the Shanghai Innovation Center for High-End Medical Equipment, exerting extensive influence within China’s medical device industry.

HiMed was jointly initiated by Yanxitang, a national-level enterprise incubator, together with more than 30 partners from the medical industry, investment sector, universities, and research institutions. Integrating investment, incubation, and acceleration services, HiMed is committed to becoming the leading brand in early-stage medical innovation. Its portfolio includes brands such as the HiMed Medical Innovators Community, HiMed MedTech Space, HiMed International Medical Innovation Center, and HiMed Angel Fund, providing one-stop incubation and acceleration for high-quality medical projects from both domestic and international markets, from concept to commercialization. Yanxitang Incubator is a well-established incubator in the biomedicine field, located in Zhangjiang Science City, Shanghai. It operates four innovation bases with a total incubation area of 20,000 square meters. In 2016, it was awarded the title of “National-Level Enterprise Incubator” (Document No. [2016] 418 issued by the Ministry of Science and Technology).

Baxter entered China in the 1980s, becoming one of the first large multinational healthcare companies to enter the Chinese medical market. Upholding its corporate mission of “Saving and Sustaining Lives,” Baxter focuses on key initiatives such as helping to raise medical standards, expanding access to healthcare, and giving back to society. It makes meaningful contributions to the lives and quality of life of patients in China, supporting the sustainable development of China’s healthcare sector. Currently, Baxter operates 11 institutions and offices, five manufacturing plants, one R&D center, and one technical service center in China.